1
|
Lee OH, Kim Y, Son NH, Cho DK, Kim JS, Kim BK, Choi D, Hong MK, Jeong MH, Jang Y. Safety and Efficacy of Contemporary Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction and a High Ischemic Risk. Front Cardiovasc Med 2022; 9:880351. [PMID: 35677690 PMCID: PMC9167955 DOI: 10.3389/fcvm.2022.880351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Accepted: 04/25/2022] [Indexed: 11/17/2022] Open
Abstract
Background In patients with ST-elevation myocardial infarction (STEMI) with a high risk of ischemic events, the safety and efficacy of drug-eluting stent (DES) are unclear. Methods Based on the nationwide, multicenter, prospective registry, we selected 1,592 patients who underwent primary percutaneous coronary intervention (PCI) with everolimus-(EES) and zotarolimus-eluting stent (ZES) for STEMI with a high risk of an ischemic event. The occurrence of target lesion failure (TLF) for 3 years, defined as the composite of cardiac death, target vessel myocardial infarction (TV-MI), and ischemia-driven target lesion revascularization (ID-TLR), was evaluated. Results The prevalence of high ischemic risk features was observed in 43.4% (2,744/6,325) of overall patients with STEMI. Among them, a total of 1,078 and 514 patients were treated with EES and ZES, respectively. At 3 years, the risk of TLF was not significantly different between the two groups (p = 0.93). In addition, the incidence of cardiac death, TV-MI, ID-TLR, and definite/probable stent thrombosis (ST) were also not different between the two groups. Moreover, elderly patients (age > 75 years) and PCI for the left main disease were identified as independent predictors of TLF. Conclusion Implantation of EES or ZES provided comparable clinical outcomes in STEMI patients and high ischemic risks.
Collapse
Affiliation(s)
- Oh-Hyun Lee
- Yonsei University College of Medicine Cardiovascular Center, Yongin Severance Hospital, Yongin-si, South Korea
| | - Yongcheol Kim
- Yonsei University College of Medicine Cardiovascular Center, Yongin Severance Hospital, Yongin-si, South Korea
| | - Nak-Hoon Son
- Data Science Team (Biostatistician), Center for Digital Health, Yongin Severance Hospital, Yongin-si, South Korea
- Department of Statistics, Keimyung University, Daegu, South Korea
| | - Deok-Kyu Cho
- Yonsei University College of Medicine Cardiovascular Center, Yongin Severance Hospital, Yongin-si, South Korea
| | - Jung-Sun Kim
- Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea
| | - Byeong-Keuk Kim
- Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea
| | - Donghoon Choi
- Yonsei University College of Medicine Cardiovascular Center, Yongin Severance Hospital, Yongin-si, South Korea
| | - Myeong-Ki Hong
- Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea
| | - Myung Ho Jeong
- Chonnam National University Hospital and Medical School, Gwangju, South Korea
| | - Yangsoo Jang
- Department of Cardiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, South Korea
| |
Collapse
|
2
|
Matsoukis IL, Karanasos A, Patsa C, Anousakis‐Vlachochristou N, Triantafyllou K, Kantzanou M, Drakopoulou M, Tsiamis E, Latsios G, Synetos A, Petridou ET, Tousoulis D, Toutouzas K. Long‐term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior descending artery. Catheter Cardiovasc Interv 2020; 98:447-457. [DOI: 10.1002/ccd.29247] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2020] [Revised: 07/14/2020] [Accepted: 08/17/2020] [Indexed: 11/05/2022]
Affiliation(s)
- Ioannis L. Matsoukis
- Department of Hygiene, Epidemiology and Medical Statistics Athens Medical School Athens Greece
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - Antonios Karanasos
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - Chrysoula Patsa
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | | | | | - Maria Kantzanou
- Department of Hygiene, Epidemiology and Medical Statistics Athens Medical School Athens Greece
| | - Maria Drakopoulou
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - Eleftherios Tsiamis
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - George Latsios
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - Andreas Synetos
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - Eleni Th Petridou
- Department of Hygiene, Epidemiology and Medical Statistics Athens Medical School Athens Greece
- Clinical Epidemiology Unit Karolinska Institute Stockholm Sweden
| | - Dimitris Tousoulis
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| | - Konstantinos Toutouzas
- 1st Cardiology Department Athens Medical School, Hippokration General Hospital Athens Greece
| |
Collapse
|
3
|
Long-term comparative effectiveness of Endeavor zotarolimus-eluting and everolimus-eluting stents in New York. Int J Cardiol 2017; 241:437-443. [PMID: 28389121 DOI: 10.1016/j.ijcard.2017.03.095] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/23/2016] [Revised: 03/01/2017] [Accepted: 03/21/2017] [Indexed: 11/21/2022]
Abstract
BACKGROUND Endeavor zotarolimus-eluting stents (E-ZES) and everolimus-eluting stents (EES) as second-generation stents were approved for use in percutaneous coronary interventions (PCIs) in 2008. We aimed to evaluate the long-term outcomes of E-ZES vs. EES using New York State (NYS) cardiac registries and to compare long-term effectiveness of E-ZES vs. EES in six "off-label" and two "high-risk" subgroups. METHODS We created a longitudinal database by linking the NYS cardiac registries, the statewide hospital discharge data, the National Death Index, and the U.S. Census file (2010) for patients receiving either E-ZES or EES from July 2008 through December 2010. We examined outcome measures of all-cause mortality, acute myocardial infarction (AMI), target lesion PCI (TLPCI), and target vessel coronary artery bypass graft (TVCABG) surgery for 13,663 propensity score matched pairs in the 6-year follow-up period. We applied Kaplan-Meier methods and Cox proportional hazards regression for further adjustment of propensity-matched pairs. RESULTS Compared with patients receiving EES, patients receiving E-ZES had a significantly higher rate of 6-year all-cause mortality (adjusted hazard ratio (AHR): 1.10, 95% confidence interval (CI): 1.04-1.17, P=0.003), AMI (AHR: 1.12, 95% CI: 1.02-1.23, P=0.01), TLPCI (AHR: 1.28, 95% CI: 1.18-1.39, P<0.001), and TVCABG (AHR: 1.47, 95% CI: 1.26-1.71, P<0.001). EES had better or similar long-term outcomes than E-ZES for the subgroups that were examined. CONCLUSION At 6years, patients receiving EES generally had better or comparable mortality, AMI, TLPCI, and TVCABG outcomes compared with patients receiving E-ZES.
Collapse
|
4
|
Di Mario C, Serruys P, Silber S, Lu S, Wang W, Widimský P, Xu B, Windecker S. Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program. EUROINTERVENTION 2016; 12:1207-1214. [DOI: 10.4244/eijv12i10a199] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
5
|
Viveiros Monteiro A, Ramos R, Fiarresga A, de Sousa L, Cacela D, Patrício L, Bernardes L, Soares C, Cruz Ferreira R. Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction. Herz 2016; 42:186-193. [PMID: 27363417 DOI: 10.1007/s00059-016-4446-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2016] [Revised: 04/30/2016] [Accepted: 05/13/2016] [Indexed: 11/30/2022]
Abstract
BACKGROUND In patients recovering from an ST-segment elevation myocardial infarction (STEMI), it is not clear whether the negative impact of stent thrombosis (ST) is different from a non-stent-related recurrent myocardial infarction (NSRMI). This study sought to assess the long-term incidence and prognostic impact of recurrent myocardial infarction (MI) after percutaneous coronary intervention (PCI) for STEMI by comparing outcomes of ST versus NSRMI. PATIENTS AND METHODS From 2001 to 2007, 1025 patients undergoing PCI for STEMI were prospectively followed up. Patients with ST, with NSRMI, and those free from recurrent MI were compared regarding mortality and major adverse cardiac and cerebrovascular events (MACCE). RESULTS Recurrent MI decreased from 37 events per 1000 person/months in the first month to 3.3 events per 1000 person/months after the first year. The cumulative 5‑year incidence of ST and NSRMI was 5.27 % and 13.2 %, respectively. MACCE at 60 months after recurrence were not significantly different for patients with reinfarction but were significantly higher than for patients free from any recurrent MI (both log-rank p < 0.001). However, the cumulative all-cause death rate did not differ between the three groups (27.8 vs. 26.7 vs. 23.0 %). Compared with ST occurring in the first 30 days after PCI for STEMI, early NSRMI was associated with a significantly reduced risk for all-cause death (HR, 0.21; 95 % CI, 0.33-3.30) but this association did not persist for recurrent MIs occurring in the late (HR, 1.05; 95 % CI, 0.33-3.30) or very late follow-up periods. CONCLUSION Although ST was associated with a significant increase in adverse events in the early recovery period, in the long term, MACCE and all-cause mortality rates were comparable to those for NSRMI.
Collapse
Affiliation(s)
- A Viveiros Monteiro
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal.
| | - R Ramos
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - A Fiarresga
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - L de Sousa
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - D Cacela
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - L Patrício
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - L Bernardes
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - C Soares
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| | - R Cruz Ferreira
- Cardiology Department, Hospital of Santa Marta, Rua de Santa Marta, 1169-1024, Lisbon, Portugal
| |
Collapse
|
6
|
Gu H, Hua K, Li W, Wang Y, Yang J. Safety and efficacy of everolimus-eluting stent versus zotarolimus-eluting stent: A meta-analysis of randomized controlled clinical trials and observational studies. Int J Cardiol 2015; 201:552-60. [DOI: 10.1016/j.ijcard.2015.02.097] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/15/2014] [Revised: 02/14/2015] [Accepted: 02/21/2015] [Indexed: 11/16/2022]
|
7
|
Ganjehei L, Rashid UM, Payami S, Saal AK. ST elevation myocardial infarction: recent advances and updates. Future Cardiol 2014; 10:633-66. [PMID: 25354034 DOI: 10.2217/fca.14.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
ST elevation myocardial infarction (STEMI) remains a leading cause of morbidity, mortality and disability worldwide. Statistically, a trend towards improvements in morbidity and mortality has been consistent over the years, which is attributed primarily to the modification of risk factors, healthier lifestyles, treatment advances and better management of door-to-balloon times via STEMI systems. However, a major challenge in the coming years will be the baby boomers (born between the years 1946 and 1964) coming into old age. The first baby boomers turned 65 in year 2011. As the baby boomers age in the coming years, the incidence of coronary heart disease is likely to increase, and so there will be a greater need to have major advances in the management of coronary heart disease in order to deal with this additional incidence. The scope of this article is to review recent advances in the management of STEMI and to provide an updated overview.
Collapse
Affiliation(s)
- Leila Ganjehei
- Department of Cardiology, University of Cincinnati, Cincinnati, OH, USA
| | | | | | | |
Collapse
|
8
|
Omar A, Torguson R, Kitabata H, Pendyala LK, Loh JP, Magalhaes MA, Satler LF, Suddath WO, Pichard AD, Waksman R. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome. Catheter Cardiovasc Interv 2014; 84:1053-60. [DOI: 10.1002/ccd.25469] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2013] [Accepted: 03/01/2014] [Indexed: 11/12/2022]
Affiliation(s)
- Alfazir Omar
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - Rebecca Torguson
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - Hironori Kitabata
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | | | - Joshua P. Loh
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - Marco A. Magalhaes
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - Lowell F. Satler
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - William O. Suddath
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - Augusto D. Pichard
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| | - Ron Waksman
- Division of Cardiology; MedStar Washington Hospital Center; Washington DC
| |
Collapse
|
9
|
Zhang XL, Li R, Wu H, Chen QH, Li GN, Xie J, Xu B. Head-to-head comparison of everolimus-eluting stents versus zotarolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis. Int J Cardiol 2014; 172:e203-6. [DOI: 10.1016/j.ijcard.2013.12.153] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2013] [Revised: 12/23/2013] [Accepted: 12/26/2013] [Indexed: 10/25/2022]
|
10
|
Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry. Catheter Cardiovasc Interv 2013; 83:436-42. [DOI: 10.1002/ccd.25169] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2013] [Revised: 07/11/2013] [Accepted: 08/22/2013] [Indexed: 11/07/2022]
|